Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression

Hyo-eun C Bhang ¹, Kathleen L Gabrielson , John Laterra

⁰Department of Pharmacology and Molecular Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Nature Medicine +

|

December 15, 2010

View abstract on PubMed

Summary

Researchers developed a new molecular imaging system using the PEG-3 promoter to detect tiny tumors in mouse models. This advance could improve cancer imaging and therapy by tracking gene expression in specific tissues.

Area Of Science

Molecular imaging
Oncology
Gene expression analysis

Background

Molecular-genetic imaging is transitioning from preclinical research to clinical patient management.
Current strategies involve reporter genes and imaging agents to monitor biological processes in vivo.
Tissue-specific promoters are crucial for targeted gene expression detection, often requiring amplification.

Purpose Of The Study

To evaluate the efficacy of the progression elevated gene-3 (PEG-3) promoter for driving imaging reporters.
To assess the PEG-3 promoter's ability to detect micrometastatic disease in cancer models.
To explore the potential of PEG-3 promoter-driven systems for cancer imaging and therapy.

Main Methods

Utilized the PEG-3 promoter, derived from a gene associated with tumor progression and metastasis.
Drove imaging reporters (bioluminescence and radionuclide-based) selectively using the PEG-3 promoter.
Tested the system in mouse models of human melanoma and breast cancer to detect micrometastases.

Main Results

The PEG-3 promoter successfully drove imaging reporters selectively in mouse models.
The system enabled the detection of micrometastatic disease in melanoma and breast cancer models.
Demonstrated strong promoter activity and tumor specificity.

Conclusions

The PEG-3 promoter is a viable tool for driving imaging reporters for cancer detection.
PEG-3 promoter-driven gene expression offers a practical system for facilitating cancer imaging.
This approach holds potential for clinical translation in cancer imaging and therapy.

Related Concept Videos